Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.

Katie BechmanMark YatesKirsty MannDeepak NagraLaura-Jane SmithAndy I RutherfordAmit PatelJimstan PeriselnerisDavid WalderRichard J B DobsonZeljko KraljevicJames H T TeoWilliam BernalRichard BarkerJames B GallowaySam Norton

Published in: PloS one (2022)

There has been substantial improvements in COVID-19 mortality in the second wave, even accounting for demographics, comorbidity, and disease severity. Neither dexamethasone nor remdesivir appeared to be key explanatory factors, although there may be unmeasured confounding present.

Keyphrases

coronavirus disease
sars cov
cardiovascular events
risk factors
palliative care
mental health
respiratory syndrome coronavirus
low dose
cardiovascular disease
cross sectional